⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28062157 | 0.81 | — | — | |
| SCHEMBL10762332 | 0.73 | — | — | |
| SCHEMBL2887142 | 0.72 | — | — | |
| SCHEMBL22658 | 0.72 | — | — | |
| Butanol SCHEMBL27305708 | 0.70 | — | — | |
| SCHEMBL130701 | 0.70 | — | — | |
| SCHEMBL8374236 | 0.69 | — | — | |
| SCHEMBL4401537 | 0.69 | — | — | |
| SCHEMBL10371642 | 0.67 | — | — | |
| SCHEMBL4482087 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010423-A1 | TRANSPARENT COMPOSITION | Evonik Operations GmbH (DE) | 2022-06-15 | — | — | EP | disclosed |
| CN-114207018-A | Transparent composition | 赢创运营有限公司 | 2022-03-18 | — | — | CN | disclosed |
| WO-2021023699-A1 | TRANSPARENT COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2021-02-11 | — | — | WO | disclosed |
| EP-1648534-B2 | ANTIMICROBIAL MEDICAL DEVICES | NOVARTIS AG (CH) | 2018-11-14 | — | — | EP | disclosed |
| US-9612455-B2 | Extended wear ophthalmic lens | NOVARTIS AG (CH) | 2017-04-04 | — | — | US | disclosed |
| US-20140022507-A1 | Extended Wear Ophthalmic Lens | CIBA VISION CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-8568626-B2 | Extended wear ophthalmic lens | CIBA VISION CORPORATION (US) | 2013-10-29 | — | — | US | disclosed |
| US-20130228943-A1 | ANTIMICROBIAL MEDICAL DEVICES | NOVARTIS AG (CH) | 2013-09-05 | — | — | US | disclosed |
| US-20130224309-A1 | ANTIMICROBIAL MEDICAL DEVICES | NOVARTIS AG (CH) | 2013-08-29 | — | — | US | disclosed |
| US-8425926-B2 | Extended wear contact lens containing uniformly distributed silver nanoparticles; simultaneous molding dispersion polymerization and cation reduction production | ALCON INC. (CH) | 2013-04-23 | — | — | US | disclosed |
| WO-2002097481-A1 | POLYMERIC MATERIALS FOR MAKING CONTACT LENSES | NOVARTIS AG (CH) | 2002-12-05 | — | — | WO | disclosed |
| EP-0819258-B1 | EXTENDED WEAR OPHTHALMIC LENS | NOVARTIS AG (CH) | 2001-09-12 | — | — | EP | disclosed |
| EP-1043605-A1 | Extended wear ophthalmic lens | Novartis AG (CH) | 2000-10-11 | — | — | EP | disclosed |
| US-5965631-A | FORMED OF POLYMERIC MATERIAL: AN OXYPERM POLYMERIZABLE MATERIAL AND IONOPERM POLYMERIZABLE MATERIAL; LENS HAS A BALANCE OF OXYGEN PERMEABILITY AND ION OR WATER PERMEABILITY TO PROVIDE GOOD ON-EYE MOVEMENT WITHOUT CORNEAL SWELLING | CIBA VISION CORPORATION (US) | 1999-10-12 | — | — | US | disclosed |
| US-5849811-A | Extended wear ophthalmic lens | CIBA VISION CORPORATION (US) | 1998-12-15 | — | — | US | disclosed |
| US-5789461-A | BIOCOMPATIBLE LENS HAVING HIGH OXYGEN PERMEABILITY AND HIGH WATER PERMEABILITY | CIBA VISION CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| US-5776999-A | BALANCE OF OXYGEN AND WATER PERMEABILITY | CIBA VISION CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| US-5760100-A | OXYGEN AND ION OR WATER PERMEABILITY | CIBA VISION CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0819258-A1 | EXTENDED WEAR OPHTHALMIC LENS | Novartis AG (CH) | 1998-01-21 | — | — | EP | disclosed |
| WO-1996031792-A1 | EXTENDED WEAR OPHTHALMIC LENS | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | disclosed |